Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
China
· Delayed Price · Currency is CNY 16.21
+0.96 (6.30%)
Apr 29, 2026, 3:04 PM CST
SHE:002755 Revenue
Beijing Aosaikang Pharmaceutical had revenue of 481.78M CNY in the quarter ending March 31, 2026, a decrease of -5.26%. This brings the company's revenue in the last twelve months to 1.75B, down -4.65% year-over-year. In the year 2025, Beijing Aosaikang Pharmaceutical had annual revenue of 1.78B with 0.08% growth.
Revenue (ttm)
1.75B
Revenue Growth
-4.65%
P/S Ratio
7.96
Revenue / Employee
1.80M
Employees
988
Market Cap
14.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.78B | 1.38M | 0.08% |
| Dec 31, 2024 | 1.78B | 334.18M | 23.15% |
| Dec 31, 2023 | 1.44B | -429.11M | -22.92% |
| Jan 1, 2023 | 1.87B | -1.23B | -39.72% |
| Jan 1, 2022 | 3.11B | -676.02M | -17.87% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Hepalink Pharmaceutical Group | 5.48B |
| Zhejiang Medicine | 8.82B |
| Nanjing King-Friend Biochemical Pharmaceutical | 3.76B |
| Shanghai Haoyuan Chemexpress | 2.88B |
| Guangdong Zhongsheng Pharmaceutical | 2.45B |
| Guobang Pharma | 6.09B |
| Shenzhen Kangtai Biological Products | 2.66B |
| Zhejiang Hisun Pharmaceutical | 10.31B |